Skip to content

Multicenter study of echocardiography and new technique in evaluating cardiac function in pregnant women with hypertensive disorder complicating pregnancy

Multicenter study of echocardiography and new technique in evaluating cardiac function in pregnant women with hypertensive disorder complicating pregnancy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027244
Enrollment
Unknown
Registered
2019-11-06
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive disorder complicating pregnancy

Interventions

Gold Standard:Blood pressure, clinical performance and laboratory tests of patients
Index test:ultrasound&#32
data&#32

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Hypertension during pregnancy: Hypertension occurs after 20 weeks of gestation, systolic blood pressure >= 140mmHg and/or diastolic blood pressure >= 90mmHg, and return to normal within 12 weeks after delivery; urine protein (-). 2. Pre-eclampsia: systolic blood pressure >= 140mmHg and/or diastolic blood pressure >= 90mmHg after 20 weeks of gestation, accompanied by urinary protein >= 0.3g / 24h or random urine protein (+); or no proteinuria, but combined Any of the following: thrombocytopenia (platelets 1.1 mg / dl or 2 times more than normal value); pulmonary edema; new central nervous system abnormalities or visual disturbances. 3. Preeclampsia: maternal convulsions based on preeclampsia, and cannot be explained by other reasons.

Exclusion criteria

Exclusion criteria: 1. primary hypertension. 2. multiple pregnancy. 3. pregnant women who has given birth to a child. 4. except for congenital heart disease, valvular heart disease, hypertrophic cardiomyopathy, dilated cardiomyopathy and acute left heart failure and other heart diseases.

Design outcomes

Primary

MeasureTime frame
accuracy rate;specificity;sensitivity;

Countries

China

Contacts

Public ContactJiawei Tian

The Second Affiliated Hospital of Harbin Medical University

jwtian2004@163.com+86 18686822228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026